The Association between Glycosylated Hemoglobin Level and Platelets Reactivity in Patients with Diabetes Mellitus Undergoing Elective Coronary Artery Bypass Grafting.
Martina Zrno MihaljevicMate PetricevicSanja KonosicLucija SvetinaMarjan UrlicZrinka StarcevicKristina KrzeljMilan MilosevicViktor KalamarHrvoje GasparovicBojan BiocinaPublished in: The Thoracic and cardiovascular surgeon (2022)
Perioperative assessment of platelet reactivity in diabetic patients detects those with AR who may be at increased risk of adverse ischemic events. A personalized approach guided by MEA and administration of early and more potent antiaggregation therapy after CABG can be beneficial in this group of patients.
Keyphrases
- coronary artery bypass grafting
- coronary artery disease
- end stage renal disease
- percutaneous coronary intervention
- patients undergoing
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- cardiac surgery
- stem cells
- acute coronary syndrome
- ischemia reperfusion injury
- patient reported outcomes
- red blood cell
- acute kidney injury
- brain injury
- mesenchymal stem cells
- adverse drug
- atrial fibrillation